Alligator Bioscience AB
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2000-01-01
- Employees
- 58
- Market Cap
- -
Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Interventions
- Biological: CD40 agonist mitazalimab in combination with chemotherapy
- First Posted Date
- 2021-05-17
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 94
- Registration Number
- NCT04888312
- Locations
- 🇪🇸
Hospital Universitario Virgen del Rocio, Sevilla, Spain, Sevilla, Spain
🇧🇪Cliniques Universitaires St-Luc, Brussels, Belgium
🇧🇪Hospital Erasme, Bruxelles, Belgium
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017
- Conditions
- Solid TumorNeoplasms
- Interventions
- Biological: ATOR-1017
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 27
- Registration Number
- NCT04144842
- Locations
- 🇸🇪
Department of Oncology, Skåne University Hospital, Lund, Sweden
🇸🇪Fas 1-enheten, Centrum för Kliniska Cancerstudier, Karolinska Universitetssjukhuset, Solna, Sweden
🇸🇪Department of Oncology, Uppsala University Hospital, Uppsala, Sweden
Phase 1 Study in Patients With Advanced and/or Refractory Solid Malignancies to Evaluate the Safety of ATOR-1015
- Conditions
- Solid TumorNeoplasms
- Interventions
- Biological: ATOR-1015
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 33
- Registration Number
- NCT03782467
- Locations
- 🇩🇰
Phase 1 Unit, Department of Oncology, Rigshospitalet, Copenhagen, Denmark
🇩🇰Center for Cancer Research, Department of Oncology, Herlev Hospital, Herlev, Denmark
🇸🇪Kliniska Prövningsenheten, Kliniska Studier Sverige - Forum Söder, Skånes Universitetssjukhus, Lund, Sweden
ADC-1013 First-in-Human Study
- Conditions
- NeoplasmsSolid Tumors
- Interventions
- Biological: ADC-1013
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Alligator Bioscience AB
- Target Recruit Count
- 24
- Registration Number
- NCT02379741
- Locations
- 🇸🇪
Kliniska prövningsenheten (KPE), Karolinska University Hospital, Solna, Stockholm, Sweden
🇩🇰Center for Cancer Research, Department of Oncology, Herlev Hospital, Herlev, Denmark
🇬🇧The Clatterbridge Cancer Centre, Bebington, Wirral, United Kingdom